You are here
Marcello Moccia, Raffaele Palladino, Antonio Carotenuto, Cinzia Valeria Russo, Maria Triassi, Roberta Lanzillo, Vincenzo Brescia Morra
Multiple Sclerosis and Related Disorders, November 2016, Pages 90 - 96
Tuncay Gündüz, Murat Kürtüncü, Mefkure Eraksoy
Multiple Sclerosis and Related Disorders, January 2017, Pages 1 - 3
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up
Carrie M. Hersh, Thomas E. Love, Samuel Cohn, Claire Hara-Cleaver, Robert A. Bermel, Robert J. Fox, Jeffrey A. Cohen, Daniel Ontaneda
Multiple Sclerosis and Related Disorders, Volume 10, November 2016, Pages 44 - 52
- Nurses are well-positioned to address medication nonadherence, which is a common concern when treating multiple sclerosis, according to a presentation at the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers, held May 27–30 in Indianapolis. Nonadherence leads to more inpatient...
- According to Professor Comi, there had been enormous advances in multiple sclerosis treatment since 1993, when interferon beta-1b was standard...